CoChat
Sign Up
Cited by 1,062Cardiac Ischemia and ReperfusionOrgan Transplantation Techniques and OutcomesCell death mechanisms and regulation

The DOI matches its Crossref record; 423 of the 423 references it cites were found in a registry or an index.

Preconditioning the Myocardium: From Cellular Physiology to Clinical Cardiology

YELLON, DEREK M., DOWNEY, JAMES M.·2003·Physiological Reviews
DOI 10.1152/physrev.00009.2003
Open this paper in CoChat — free account

Abstract

Yellon, Derek M., and James M. Downey. Preconditioning the Myocardium: From Cellular Physiology to Clinical Cardiology. Physiol Rev 83: 1113-1151, 2003; 10.1152/physrev.00009.2003.—The phenomenon of ischemic preconditioning, in which a period of sublethal ischemia can profoundly protect the cell from infarction during a subsequent ischemic insult, has been responsible for an enormous amount of research over the last 15 years. Ischemic preconditioning is associated with two forms of protection: a classical form lasting ∼2 h after the preconditioning ischemia followed a day later by a second window of protection lasting ∼3 days. Both types of preconditioning share similarities in that the preconditioning ischemia provokes the release of several autacoids that trigger protection by occupying cell surface receptors. Receptor occupancy activates complex signaling cascades which during the lethal ischemia converge on one or more end-effectors to mediate the protection. The end-effectors so far have eluded identification, although a number have been proposed. A range of different pharmacological agents that activate the signaling cascades at the various levels can mimic ischemic preconditioning leading to the hope that specific therapeutic agents can be designed to exploit the profound protection seen with ischemic preconditioning. This review examines, in detail, the complex mechanisms associated with both forms of preconditioning as well as discusses the possibility to exploit this phenomenon in the clinical setting. As our understanding of the mechanisms associated with preconditioning are unravelled, we believe we can look forward to the development of new therapeutic agents with novel mechanisms of action that can supplement current treatment options for patients threatened with acute myocardial infarction.

Overview

Integrity signals

Registry

Crossref · 10.1152/physrev.00009.2003

Cites

423 of 423 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Items 401–423 of 423

Flagged first, then by citations

Research works printed but not linked: 3

  1. 10.1161/hc4401.098429 · DOI
  2. 10.1172/JCI0214270 · DOI
  3. 10.1038/sj.bjp.0703594 · DOI

Cited by

Sorted by citations

See all 1,062

Related

See all

Metadata

Authors
YELLON, D. M., & DOWNEY, J. M.
Affiliations
University College Hospital (GB)
ORCID
Venue
Physiological Reviews
Publisher
American Physiological Society
Published
2003-10
Volume
83
Issue
4
Pages
1113-1151
ISSN
  • 0031-9333 (ISSN-L)
  • 1522-1210
DOI
10.1152/physrev.00009.2003
OpenAlex
W2047876380
Cited by
1,062
References
423
Citations by year
2026: 9 · 2025: 12 · 2024: 18 · 2023: 17 · 2022: 19 · 2021: 28 · 2020: 23 · 2019: 25 · 2018: 30 · 2017: 30 · 2016: 51 · 2015: 41 · 2014: 41 · 2013: 64 · 2012: 73
FWCI
8.24
Type
journal article
Language
en
Open access
closed
Locations
  • Physiological Reviews (publishedVersion)
  • PubMed (publishedVersion)
  • UCL Discovery (University College London) (submittedVersion)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Ischemia and Reperfusion
  • Health Sciences › Medicine › Surgery › Organ Transplantation Techniques and Outcomes
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
Keywords
ischemic preconditioning, myocardial infarction, cardioprotection, autacoids, second window of protection, pharmacological preconditioning
MeSH terms
Animals, Humans, Myocardium, Myocardial Ischemia, Ischemic Preconditioning, Myocardial, Myocytes, Cardiac

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review